PrecisionMed Inc.

Collaboration seeks to develop noninvasive diagnostics for Alzheimer disease

Published in Medicine and Law Weekly, March 11th, 2005

PrecisionMed Inc. and Phenomenome Discoveries Inc. (PDI) announced the undertaking of a collaboration to develop noninvasive diagnostics for Alzheimer disease and bipolar disorder using PrecisionMed's clinical samples and information, and PDI's proprietary diagnostics discovery and testing platform.

PDI's metabolomics-based technology enables the discovery of metabolites that differ between healthy controls and people with Alzheimer disease and bipolar disorder. Such diagnostic metabolites can be used for the early detection of disease, as well as to optimize and measure response to treatment regimes.

"The scientific value of genetic samples is a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry